Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings

Shares (Q2 2026)
87,487
Value
$1.51M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of AMRX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202687,487$1.51M<0.1%−189,150−68.4%ReducedHolders
Q1 2026276,637$3.44M<0.1%+260,237+1,586.8%AddedHolders
Q4 202516,400$206.6K<0.1%−73,500−81.8%ReducedHolders
Q3 202589,900$899.9K<0.1%−338,100−79.0%ReducedHolders
Q2 2025428,000$3.46M<0.1%−196,700−31.5%ReducedHolders
Q1 2025624,700$5.23M<0.1%−61,800−9.0%ReducedHolders
Q4 2024686,500$5.44M<0.1%−69,100−9.1%ReducedHolders
Q3 2024755,600$6.29M<0.1%+72,900+10.7%AddedHolders
Q2 2024682,700$4.34M<0.1%+149,970+28.2%AddedHolders
Q1 2024532,730$3.23M<0.1%+324,930+156.4%AddedHolders
Q4 2023207,800$1.26M<0.1%+93,700+82.1%AddedHolders
Q3 2023114,100$482.0K<0.1%+114,100NewHolders
Q1 20230$00.0%−76,400−100.0%Sold outHolders
Q4 202276,400$152.0K<0.1%−65,500−46.2%ReducedHolders
Q3 2022141,900$287.0K<0.1%−30,500−17.7%ReducedHolders
Q2 2022172,400$548.0K<0.1%+103,800+151.3%AddedHolders
Q1 202268,600$286.0K<0.1%+68,600NewHolders
Q2 20210$00.0%−448,660−100.0%Sold outHolders
Q1 2021448,660$3.02M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.